PMC:1064895 / 4060-4336 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4160 12-16 NN denotes bone
T4161 17-27 NN denotes resorption
T4162 28-30 IN denotes by
T4163 31-34 DT denotes the
T4164 35-44 NN denotes induction
T4165 45-47 IN denotes of
T4166 48-53 NNP denotes RANKL
T4167 54-55 -LRB- denotes (
T4168 55-63 NN denotes receptor
T4169 64-73 NN denotes activator
T4170 74-76 IN denotes of
T4171 77-84 JJ denotes nuclear
T4172 85-91 NN denotes factor
T4173 92-94 NNP denotes κB
T4174 95-96 NNP denotes [
T4175 96-101 NNP denotes NF-κB
T4176 101-102 NNP denotes ]
T4177 103-109 NN denotes ligand
T4178 109-110 -RRB- denotes )
T4179 110-111 , denotes ,
T4180 112-117 WDT denotes which
T4181 118-120 VBZ denotes is
T4182 121-129 VBN denotes involved
T4183 130-132 IN denotes in
T4184 133-137 NN denotes bony
T4185 138-145 NN denotes erosion
T4186 146-148 IN denotes in
T4187 149-151 NNP denotes RA
T4188 152-153 NNP denotes [
T4189 153-154 CD denotes 7
T4190 154-155 NNP denotes ]
T4191 155-156 . denotes .
T4192 157-159 PRP denotes It
T4193 160-164 RB denotes also
T4194 165-175 VBZ denotes stimulates
T4195 176-179 DT denotes the
T4196 180-190 NN denotes production
T4197 191-193 IN denotes of
T4198 194-198 NN denotes IL-6
T4199 199-202 CC denotes and
T4200 203-211 NN denotes leukemia
T4201 212-222 JJ denotes inhibitory
T4202 223-229 NN denotes factor
T4203 230-232 IN denotes by
T4204 233-245 NNS denotes synoviocytes
T4205 245-246 , denotes ,
T4206 247-250 CC denotes and
T4207 251-253 IN denotes of
T4208 254-267 NN denotes prostaglandin
T4209 268-270 CD denotes E2
T4210 271-274 CC denotes and
R2146 T4160 T4161 compound bone,resorption
R2150 T4163 T4164 det the,induction
R2151 T4164 T4162 pobj induction,by
R2152 T4165 T4164 prep of,induction
R2154 T4166 T4165 pobj RANKL,of
R2155 T4167 T4169 punct (,activator
R2156 T4168 T4169 compound receptor,activator
R2158 T4169 T4166 appos activator,RANKL
R2159 T4170 T4169 prep of,activator
R2160 T4171 T4172 amod nuclear,factor
R2162 T4172 T4170 pobj factor,of
R2163 T4173 T4177 compound κB,ligand
R2164 T4174 T4177 compound [,ligand
R2166 T4175 T4177 compound NF-κB,ligand
R2167 T4176 T4177 compound ],ligand
R2168 T4177 T4172 appos ligand,factor
R2170 T4178 T4177 punct ),ligand
R2171 T4179 T4172 punct ",",factor
R2172 T4180 T4182 nsubjpass which,involved
R2174 T4181 T4182 auxpass is,involved
R2175 T4182 T4172 relcl involved,factor
R2176 T4183 T4182 prep in,involved
R2178 T4184 T4185 amod bony,erosion
R2179 T4185 T4183 pobj erosion,in
R2181 T4186 T4185 prep in,erosion
R2182 T4187 T4188 compound RA,[
R2183 T4188 T4186 pobj [,in
R2184 T4189 T4190 nummod 7,]
R2185 T4190 T4166 conj ],RANKL
R2188 T4192 T4194 nsubj It,stimulates
R2189 T4193 T4194 advmod also,stimulates
R2190 T4194 T4194 ROOT stimulates,stimulates
R2191 T4195 T4196 det the,production
R2193 T4196 T4194 dobj production,stimulates
R2194 T4197 T4196 prep of,production
R2195 T4198 T4197 pobj IL-6,of
R2197 T4199 T4198 cc and,IL-6
R2198 T4200 T4202 nmod leukemia,factor
R2199 T4201 T4202 amod inhibitory,factor
R2201 T4202 T4196 conj factor,production
R2203 T4203 T4196 prep by,production
R2205 T4204 T4203 pobj synoviocytes,by
R2206 T4205 T4194 punct ",",stimulates
R2208 T4206 T4194 cc and,stimulates
R2209 T4207 T4194 conj of,stimulates
R2210 T4208 T4207 pobj prostaglandin,of
R2212 T4209 T4208 nummod E2,prostaglandin
R2213 T4210 T4208 cc and,prostaglandin